AI assistant
TALPHERA, INC. — Director's Dealing 2021
Feb 9, 2021
35181_dirs_2021-02-09_0c8ef221-4ed3-42a5-ad95-8ac175d6eae6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ACELRX PHARMACEUTICALS INC (ACRX)
CIK: 0001427925
Period of Report: 2021-02-06
Reporting Person: Palmer Pamela P (Director, Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-06 | Common Stock | F | 9414 | $2.59 | Disposed | 602013 | Direct |
Footnotes
F1: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.
F2: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
F3: Balance includes acquisitions of 4,323 and 4,681 shares of Common Stock through the Company's Employee Stock Purchase Plan and reflects the correction of the overreporting of 2,560 ESPP shares purchased on February 29, 2016.